A Double-Blind, Randomized, Placebo-Controlled, Parallel, Time-Lagged, Ascending, Multi-Centre, Multiple-Dose Study to Measure the Magnitude and Time Course of the Effect of FTY720 on FEV1 and Other Pulmonary Function Tests (FVC, FEF25-75%, and FEV1/FVC) in Patients With Moderate Asthma.
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Fingolimod (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 16 Nov 2011 Actual initiation date changed from Sep 2008 to May 2008 as reported by European Clinical Trials Database record.
- 16 Nov 2011 New source identified and integrated (European Clinical Trials Database: EudraCT2007-001714-16)
- 13 Apr 2010 Results presented at the 62nd Annual Meeting of the American Academy of Neurology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History